Concord Wealth Partners Orchard Therapeutics PLC Transaction History

Concord Wealth Partners

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 27, 2023	BUY	$0.36 - $0.49 $360 - $490	1,000 New	1,000 $0
Q1 2022 Apr 20, 2022	BUY	$0.7 - $1.51 $420 - $906	600 Added 150.0%	1,000 $1,000
Q2 2021 Jul 29, 2021	BUY	$4.39 - $7.23 $877 - $1,446	200 Added 100.0%	400 $2,000
Q1 2021 May 13, 2021	BUY	$4.39 - $9.08 $877 - $1,816	200 New	200 $1,000

545K

Ticker ORTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 126,458,000
Description
Orchard Therapeutics plc, a biopharmaceutical company, develops gene therapies for serious and life-threatening rare diseases in the United Kingdom, European Union, and the United States. The company's gene therapy approach seeks to transform a patient's hematopoietic stem cells into a gene-modified cellular drug product to treat the patient's d...

Get notified when there are updates to the investment portfolio of Concord Wealth Partners, based on Form 13F filings with the SEC.

Stay updated on Concord Wealth Partners with notifications on news.